ClinicalTrials.gg
RecruitingNCT07071207TextMsgM-ISIUpdated Nov 6, 2025

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

An interventional study of Text message reminders in Incontinence, Urinary Stress, Prostate Cancer and Benign Prostate Hyperplasia, sponsored by University of Rochester. Recruiting at 1 site in United States. Open to male participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-06.

Sponsored by University of Rochester · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Sep 2025; still recruiting 1 year 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 190 studies in Urinary Incontinence, Stress with a site in United States — 28 open to participants now, 41 under way, 4 of them phase 3. Urinary Incontinence, Stress · United States.

Planned enrollment
66th of 164
132 · median 99
Started
2025
with 12 others
No phase
109 of 190
18 open now
Primary completion
2028-05
later than 28 of 40 live
Registered
179th of 190
by date

Among the 190 studies in Urinary Incontinence, Stress with a site in United States, this one is the 66th largest by planned enrollment of the 164 interventional ones that give a count, is one of 13 that started in 2025, is one of 109 with no phase, reaches primary completion later than 28 of the 40 other live ones, and was the 179th registered.

Urinary Incontinence, Stress

655 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

28 of the 190 studies in Urinary Incontinence, Stress with a site in United States are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 76 Urinary Incontinence, Stress studies recruiting now, 43 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 18 Years and older · male · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 190 studies in Urinary Incontinence, Stress with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to compare post-prostatectomy incontinence via Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises when compared to those not receiving text reminders.

Read the detailed description

This trial will be comprised of prostate cancer patients who have undergone a radical prostatectomy and benign prostate hyperplasia patients who have undergone a laser enucleation of the prostate. These two cohorts will each be split into an intervention and a control group. The purpose of this study is to evaluate post-prostatectomy incontinence via patient reported outcomes utilizing Michigan Incontinence Score Index in patients receiving daily text message reminders for pelvic floor exercises + standard of care (intervention group) compared to those receiving standard of care only (control group).

03

Conditions studied

  • Incontinence, Urinary Stress
  • Prostate Cancer
  • Benign Prostate Hyperplasia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Planning to undergo a radical prostatectomy (RALP) or laser enucleation of the prostate (LEP) procedure
  2. Patient of URMC Urology
  3. Adult male 18 years of age and older
  4. Able to read, write, and speak in English (NOTE: due to limitations with questionnaire validation, only English-speaking subjects are permitted)
  5. Has access to a mobile device capable of receiving automated text messages.
  6. Willing to receive text messages and to complete questionnaires via SMS text.
  7. Willingness to participate and able to provide .

Exclusion criteria

Exclusion Criteria:

  1. Less than 18 years of age
  2. Unable to send and receive SMS texts
  3. Unable to read, write, and speak English
  4. Catheter dependency
  5. Has or plans to have Artificial Urinary Sphincter or Urethral Sling during the study period
  6. In the opinion of the investigator, the subject has a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the study, interfere with the subject's participation for the full duration of the study, or is not in the best interest of the subject to participate.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (estimated)

Study arms

  • No intervention
    Control group - LEP surgery patients

    Patients undergoing LEP surgery and standard of care discharge instructions to perform pelvic floor exercises

  • Experimental
    Intervention group - LEP surgery patients

    Patient undergoing LEP surgery with text message intervention to perform pelvic floor exercises as described in the schedule of events

    Behavioral: Text message reminders

  • No intervention
    Control group - RALP surgery patients

    Patients undergoing RALP surgery and standard of care discharge instructions to perform pelvic floor exercises

  • Experimental
    Intervention group - RALP surgery patients

    Patient undergoing RALP surgery with text message intervention to perform pelvic floor exercises as described in the schedule of events

    Behavioral: Text message reminders

Interventions

  • BehavioralText message reminders

    daily 8am text messages reminding patients to perform Kegel exercises as per their standard-of-care post-operative discharge instructions.

06

What researchers measure

Primary outcomes

  1. Time to Recovery to Continence

    The time it takes for participants to recover continence, as defined by two successive M-ISI Pad Use Subdomain Scores of ≤ 2. The Pad Use Subdomain Score is determined by the sum of items Q7-8 from the M-ISI questionnaire, assessed as a time-to-event outcome.

    Time frame: From baseline until the participant reaches two successive M-ISI Pad Use Subdomain Scores of ≤ 2, assessed up to 12 months

07

Study locations

1 of 1 sites recruiting
  • 158 Sawgrass clinic; Suite 3100
    Rochester, New York 14620, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2025 (actual). Primary completion is estimated for May 2028, 31 months after the start.

Of 227 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 31 months is above that.

Counting every sponsor, half of 268 studies reached it within 19 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 7, 2025
First posted
Jul 17, 2025
StartActual
Sep 15, 2025
Primary completionEst.
May 1, 2028
CompletionEst.
May 1, 2028
Last update
Nov 6, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 6, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07071207
Responsible party
Scott Quarrier (Assistant professor, University of Rochester) — Principal investigator
First posted
Jul 17, 2025
Start date
Sep 15, 2025
Primary completion
May 1, 2028 (estimated)
Completion
May 1, 2028 (estimated)
Last update
Nov 6, 2025

Study contacts

Austin Jackson
Contact
Austin_jackson@urmc.rochester.edu
(585) 275-0126

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion